Wiki-MPM
About
Search
Browse
People
Funding
Updates
Search
SNTA1 and SCN4A
Data Source:
BioGRID
(unspecified method)
HPRD
(in vivo)
SNTA1
SCN4A
Description
syntrophin alpha 1
sodium voltage-gated channel alpha subunit 4
Image
No pdb structure
GO Annotations
Cellular Component
Intracellular Anatomical Structure
Cytoplasm
Cytoskeleton
Dystrophin-associated Glycoprotein Complex
Syntrophin Complex
Lateral Plasma Membrane
Neuromuscular Junction
Protein-containing Complex
Sarcolemma
Synapse
Postsynaptic Membrane
Voltage-gated Sodium Channel Complex
Integral Component Of Plasma Membrane
Axon
Molecular Function
Actin Binding
Structural Molecule Activity
Protein Binding
Calmodulin Binding
Sodium Channel Regulator Activity
PDZ Domain Binding
Ion Channel Binding
Nitric-oxide Synthase Binding
ATPase Binding
Voltage-gated Ion Channel Activity
Voltage-gated Sodium Channel Activity
Protein Binding
Biological Process
Regulation Of Heart Rate
Regulation Of Vasoconstriction By Circulating Norepinephrine
Muscle Contraction
Neuromuscular Junction Development
Regulation Of Ventricular Cardiac Muscle Cell Membrane Repolarization
Ventricular Cardiac Muscle Cell Action Potential
Negative Regulation Of Peptidyl-cysteine S-nitrosylation
Regulation Of Sodium Ion Transmembrane Transport
Sodium Ion Transport
Muscle Contraction
Neuronal Action Potential
Regulation Of Ion Transmembrane Transport
Sodium Ion Transmembrane Transport
Membrane Depolarization During Action Potential
Regulation Of Skeletal Muscle Contraction By Action Potential
Pathways
Interaction between L1 and Ankyrins
Phase 0 - rapid depolarisation
Drugs
Ranolazine
Topiramate
Lidocaine
Valproic acid
Lamotrigine
Carbamazepine
Oxcarbazepine
Propofol
Cocaine
Zonisamide
Promethazine
Flecainide
Brivaracetam
Tetracaine
Amylocaine
Propoxycaine
Pramocaine
Pentoxyverine
Parachlorophenol
Dichlorobenzyl alcohol
Bioallethrin
Fish oil
Diseases
Long QT syndrome, including: Romano-Ward syndrome; Jervell and Lange-Nielsen syndrome (JLNS)
Hyperkalemic periodic paralysis (HyperPP)
Potassium-aggravated myotonias (PAMs), including: Myotonia fluctuans; Myotonia permanens; Acetazolamide responsive myotonia
Hypokalemic periodic paralysis (HypoPP)
Paramyotonia congenita (PMC)
Congenital myasthenic syndrome
GWAS
HDL cholesterol x physical activity interaction (1df test) (
30670697
)
HDL cholesterol x physical activity interaction (2df test) (
30670697
)
Height (
28552196
31562340
)
Interacting Genes
74 interacting genes:
ABCA1
ABCC4
ACTA2
ADAMTS6
ADGRB1
ADGRB2
ADGRB3
ADH5
ADRA1D
ADRA2A
ADRB1
AGTR2
ATP2B2
ATP6V0B
C3AR1
CALM1
CD3E
CNKSR2
COPB1
DGKZ
DMD
DTNA
DTNB
F8A1
FABP1
FAM189B
GDA
GLS
GLS2
GOLGA2
GRB2
GUCY1A2
HTR2B
HTR2C
IL2RA
IL9
ITGB5
KCNA4
KCNA5
KCNJ10
KCNJ12
KCNJ15
KCNJ4
KIF1B
LMO1
MAP4
MAPK12
MAS1
MAST1
MCM7
MED8
MTMR2
NAT1
NMU
NOS1
PFN2
PRLHR
PSKH1
RPS6KA1
SCN1A
SCN4A
SCN5A
SCTR
SLC16A7
SLC1A7
SLC2A3
SLC6A3
SSTR1
TGFA
TLX3
TRA
TRBV12-3
UTRN
XRCC6
10 interacting genes:
CALM1
DLG1
DLG2
DLG3
ERBIN
PATJ
SLC9A3R1
SNTA1
SNTB1
SNTB2
Entrez ID
6640
6329
HPRD ID
03009
04912
Ensembl ID
ENSG00000101400
ENSG00000007314
Uniprot IDs
Q13424
P35499
PDB IDs
6AGF
6MBA
6MC9
Enriched GO Terms of Interacting Partners
?
Tagcloud
?
Tagcloud (Difference)
?
Tagcloud (Intersection)
?